Telmisartan, an at1 receptor blocker and a ppar gamma activator, alleviates liver fibrosis induced experimentally by schistosoma mansoni infection

HIGHLIGHTS

• who: Hepatic fibrosis et al. from the Department of Pharmacology and Biochemistry, Faculty of Pharmacy, The British University in, Suez Desert Road, POBox, El Sherouk City have published the paper: Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection, in the Journal: (JOURNAL) of 17/06/2013
• what: This study has aimed at testing the anti-fibrogenic effects of telmisartan; an AT1 receptor blocker and PPARγ partial agonist alone or combined with praziquantel (PZQ) on mansoni-induced liver in mice. Methods: To achieve the aim . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.